Global Stem Cells Group, has announced that two GSCG Advisory Board members, Joseph Purita, M.D. and Gilberto Hernandez Falcon, M.D., will be keynote speakers at the Latin American Chapter of the American Academy of Anti-Aging Medicine (A4M) VII World Congress in Mexico City, Feb. 12, 13 and 14 2016.
MIAMI, Jan. 21, 2016—Global Stem Cells Group, a world leader in regenerative medicine, has announced that two members of its Advisory Board, Joseph Purita, M.D. and Gilberto Hernandez Falcon, M.D., will be keynote speakers at the American Academy of Anti-Aging Medicine (A4M) Latin American Chapter of the VII World Congress Feb. 12, 13 and 14 2016.
The conference will focus on recent technological and scientific advances in anti-aging medicine that are becoming indispensible in the prevention, prediction, detection, treatment and rehabilitation of diseases that occur with advancing age. This conference will focus on new treatments and protocols to extend years and improve patient quality of life.
Conference topics include recent protocols in weight control and obesity, platelet rich plasma therapies, menopause, sexual health and hormonal balance, alternative medicine for stress and sleep disorders, LED laser and thermal heat treatments, biodentical hormone replacement therapy and its clinical applications, oxygen and ozone therapies, recent advances in cellular therapies for cosmetic applications and much more.
Purita, who heads the Global Stem Cells Group Advisory Board, is a pioneer in the use of stem cell therapies in orthopedics. He will speak on the latest advances in evidence-based, best-practice protocols for the early detection, prevention and treatment of medical problems associated with aging.
The conference will be held at the Hotel Fiesta Americana Reforma in Mexico City.
For more information, visit the Global Stem Cells Group website, email info(at)stemcelltraining(dot)net, or call (305) 560-5337.
About Global Stem Cell Group:
Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
To view this press release live online, please click here